| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,492 | 0,545 | 29.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ADICON Aktie jetzt für 0€ handeln | |||||
| 30.09. | ADICON HOLDINGS (09860): MAJOR ACQUISITION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES OF THE TARGET COMPANY - EXTENSION OF OUTSIDE DATE | - | HKEx | ||
| 14.09. | ADICON HOLDINGS (09860): 2026 INTERIM REPORT | 1 | HKEx | ||
| 25.08. | Adicon Holdings Ltd H1 Sales Increase | 1 | RTTNews | ||
| 25.08. | ADICON HOLDINGS (09860): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 25.08. | ADICON HOLDINGS (09860): APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN THE COMPOSITION OF BOARD COMMITTEE | 1 | HKEx | ||
| 25.08. | ADICON HOLDINGS (09860): UPDATE ON QUALIFICATION OF COMPANY SECRETARY AND CHANGE OF JOINT COMPANY SECRETARY | 1 | HKEx | ||
| 25.08. | ADICON HOLDINGS (09860): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 | - | HKEx | ||
| 13.08. | ADICON HOLDINGS (09860): DATE OF BOARD MEETING | - | HKEx | ||
| 27.05. | ADICON HOLDINGS (09860): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 27.05. | ADICON HOLDINGS (09860): DESIGNATION OF LEAD INDEPENDENT NON-EXECUTIVE DIRECTOR | 2 | HKEx | ||
| 27.05. | ADICON HOLDINGS (09860): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 27, 2026 | 1 | HKEx | ||
| 15.05. | ADICON HOLDINGS (09860): SUPPLEMENTAL PROGRESS UPDATE ANNOUNCEMENT ON MAJOR ACQUISITION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES OF THE ... | 1 | HKEx | ||
| 13.05. | ADICON HOLDINGS (09860): PROGRESS UPDATE ANNOUNCEMENT ON MAJOR ACQUISITION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES OF THE TARGET COMPANY | - | HKEx | ||
| 05.05. | ADICON HOLDINGS (09860): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 27, 2026 | 1 | HKEx | ||
| 05.05. | ADICON HOLDINGS (09860): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 05.05. | ADICON HOLDINGS (09860): PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES AND PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS ... | 1 | HKEx | ||
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences unterzeichnet endgültige Vereinbarung zur Übertragung von Crown Bioscience an Adicon Holdings Limited | 802 | Business Wire | Strategische Transaktion positioniert Crown Bioscience für beschleunigtes Wachstum in der translationalen Onkologie
JSR Life Sciences LLC ("JSR Life Sciences"), ein weltweit führender Anbieter... ► Artikel lesen | |
| 13.11.25 | EQS Newswire: Adicon Holdings Limited: Adicon to Acquire Crown Bioscience for US$204 Million, Creating a Global End-to-End Laboratory Service Platform | 941 | EQS Group (EN) | EQS Newswire / 13/11/2025 / 16:48 UTC+8
Hangzhou, China - Nov.13, 2025 - Adicon Holdings Limited ("Adicon", 9860.HK), a leading independent clinical laboratory service provider in China and a... ► Artikel lesen | |
| 13.11.25 | Crown Bioscience Inc.: JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited | 982 | Business Wire | Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology
JSR Life Sciences LLC ("JSR Life Sciences"), a global leader in life sciences materials and services... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,34 | +0,20 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,470 | +2,14 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | Siemens Healthineers steht vor einer wichtigen Bewährungsprobe | Siemens Healthineers nähert sich einem entscheidenden Moment. Nach einer längeren Phase der Unsicherheit hat sich die Aktie zuletzt erholt, doch operativ bleibt der Medizintechnikkonzern ein Unternehmen... ► Artikel lesen | |
| FRESENIUS | 47,000 | +1,44 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,635 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,020 | -0,50 % | Alignment Healthcare Q3 2026 Earnings Call Transcript | ||
| GERRESHEIMER | 31,900 | -1,24 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| HEARTFLOW | 60,55 | +0,03 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | -0,08 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,760 | +0,12 % | Weniger Blendung bei 64 Prozent der Testpersonen: Wie ZEISS Licht im Brillenglas steuert | ||
| GENEDX | 70,98 | -0,06 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CONCENTRA GROUP | 41,250 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,420 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Schedule 14A Preliminary Proxy Statement | ||
| STARLING ONCOLOGY INSTITUTE | 6,650 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| MIMEDX | 3,975 | +0,13 % | Mizuho cuts MiMedx stock price target on wound segment weakness |